children
BioNTech seek approval for COVID-19 vaccine in children aged 5-11
September 13, 2021Sales and Marketing COVID-19, FDA, Vaccine, children
Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …
UK COVID vaccine update
June 16, 2021Research and Development COVID-19, UK, care homes, children, government, vaccines
Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
Teva launch generic version of EpiPen for children
August 21, 2019Research and Development Mylan, Teva, allergies, children, epipen, pharma
A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …
Children wait six and half years longer than adults for new cancer drugs, study says
May 22, 2019Research and Development Cancer, FDA, children, oncology, paediatrics, pharma
Children wait six and half years longer than adults to access new cancer drugs, according to a study from Dana-Farber/Boston …
Children born in poverty show major differences in brain function, study shows
April 3, 2019Research and Development India, UEA, brain development, brain function, childhood, children
Children born into poverty show major differences in early brain function, according to research from the University of East Anglia. …
Postoperative radiation can triple survival in children with brain cancer
March 6, 2019Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation
Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …
Probiotics have no effect on children with gastroenteritis, study shows
November 22, 2018Research and Development children, flu, gastroenteritis, probiotics, research
Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …
More children suffering from type 2 diabetes in England and Wales
August 20, 2018Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people
The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
Drugs should be preferred first-choice treatment for ADHD
August 8, 2018Research and Development ADHD, adults, amphetmines, children, prescription, ritalin
Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …
More antidepressants being prescribed to children in UK
July 25, 2018Research and Development antidepressants, children, mental health, prescription, young people
Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …
Surprising number of parents agree to use of placebos in children
November 16, 2016Medical Communications, Research and Development Placebo, children
A study by Boston Children’s Hospital found that parents recognised that placebos are a vital part of research and that …
Promising new study for children’s brain cancer
November 1, 2016Manufacturing and Production brain cancer, children, oncology
There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …
Second child cleared of leukaemia after Cellectis T-cell treatment
May 10, 2016Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells
A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …
Amgen’s drug reduces rates of bleeding in rare childhood disorder
April 21, 2016Research and Development, Sales and Marketing Amgen, blood disorder, children, nplate, paediatric, platelet, rare, romisplostim
Amgen (NASDAQ: AMGN) has announced the results of a Phase III trial, published in The Lancet, which shows that Nplate …
Novartis receives EU approval for blood disorder treatment in children
April 7, 2016Research and Development, Sales and Marketing EMA, EU, ITP, Novartis, Revolade, approval, blood disorder, children, chronic itp
Novartis (NYSE: NVS) has announced that Revolade (eltrombopag) has been approved in the EU for use in paediatric patients aged …
